Joindre Capital (531861)
CyclicalScore breakdown: P/E: 3/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 1/1
Key Financials
| Current Price | ₹50.92 |
| Market Cap | ₹70.46 Cr |
| P/E Ratio | 7.64 |
| ROCE | 17.28% |
| ROE | 10.24% |
| Dividend Yield | 4.64% |
| Profit Growth | 1,000% |
| Debt/Equity | — |
| Sales Growth | -9.35% |
| 52-Week Range | ₹39.5 — ₹61.95 |
| Sector | Capital Markets |
| Book Value | ₹55.24 |
Strengths
- Trading below book value: P/B 0.92 vs book value ₹55.24, offering a margin of safety if asset quality holds.
- Attractive earnings multiple: P/E 7.64 and dividend yield 4.64%, providing income while waiting for value recognition.
- Capital efficiency: ROCE 17.28% with Piotroski F-score 6/9 indicates reasonable financial health.
- Latest quarter shows recovery: ₹10 Cr sales with ₹2 Cr net profit, confirming some earnings power.
Concerns
- Top-line weakness: sales declined 9.35%, raising doubt about sustainability of the profit surge.
- Profit growth of 1000% is from a low base and is not a reliable indicator; PEG 0.01 is meaningless here.
- Stockbroking is cyclical and competitive, with no obvious durable moat or pricing power.
- Promoter holding is not disclosed, and debt/equity data is unavailable, so governance and leverage risk are unknown.
AI Analysis
Let me look at Joindre Capital the way Graham taught me. At ₹50.92, I can buy a stock in a stockbroking firm for less than its book value of ₹55.24 — a P/B of 0.92. The P/E is 7.64, and the dividend yield is 4.64%. On the surface, this is the kind of price that offers a margin of safety. But I must ask: is this a good business, or just a cheap one? Revenues fell 9.35% last year, and that troubles me. A 1000% jump in profit sounds exciting, but when the base is small, percentages can deceive. A single good quarter — ₹10 Cr in sales and ₹2 Cr in net profit — is not a trend. The Piotroski F-score of 6/9 suggests acceptable financial health, and ROCE of 17.28% is pleasant, but ROE is only 10.24%, hardly a compounding machine. Stockbroking is a competitive, cyclical business with thin moats; market volumes drive earnings, and today's activity can turn quickly. Debt data is not available, so I cannot fully judge the balance sheet, though the dividend suggests some cash generation. At below book value, this may be an asset play, but only if the book value is real and the business does not burn capital through poor operations. I would need to see stable revenue and consistent profits before treating it as a wonderful business. Cheap can remain cheap. I'll watch how management uses earnings and whether the dividend remains covered.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer